Contact us Demo our platform

Metabolon @

Live Webinar: Untargeted Metabolomics: Parsing Large Amounts of Data to Make the Most of Your Metabolomics Study

Event Details

Event Date: November 8, 2023
Time: 12 – 1 PM (EST)

Speakers

  • Greg Palczewski, Ph.D.
  • Priya Ramamoorthy, Ph.D.
  • Andrew Schwab, Ph.D.

Share this webinar

Untargeted metabolomics data has proven to be very valuable across a variety of research areas. However, the vast amounts of data generated from untargeted approaches can make utilizing metabolomics a daunting task. 

We have developed new focused Discovery Panels to help you narrow your scope of analysis while maintaining the data integrity of most of the metabolites at Level 1 detection. To make data analysis easier, we have also developed revolutionary data visualization tools to help you make sense of the metabolites detected and their impact on biological pathways. 

In this webinar, our experts will introduce you to our three new Discovery Panels, the Biological Stress Discovery Panel, the Liver Fibrosis Discovery Panel, and the Kidney Function Discovery Panel. We will also provide an in-depth look at the new MyMetabolon Portal data tools.  

You Will Learn:

During this webinar, you will learn:

  • How Metabolon has developed methods that emphasize reproducible accuracy 
  • The thought process behind the development of bioinformatics tools 
  • How you can leverage our expertise and experience for answers in your lab 

Speakers

K
L

Greg Palczewski, Ph.D.

Greg Palczewski is a Sr. Study Director within our Discovery and Translational Science team. With 130+ published reports, experience in diagnostic development, AgBiome, and a Ph.D. focused on mammalian metabolism, he brings his diverse skillset to tackle biological challenges.

K
L

Priya Ramamoorthy, Ph.D.

Priya Ramamoorthy is a Director within our Discovery and Translational Sciences team with a strong background in translational sciences and metabolomic research, over 15 years of combined experience in both academia and industry, and a proven track record of leading successful research projects and teams. As a director, she is involved in the analysis of complex metabolomic data and collaborates with scientists and clinicians to advance the adoption of metabolomics for biomarker discovery and elucidation of key molecular mechanisms.

K
L

Andrew Schwab, Ph.D.

Andrew Schwab is an accomplished scientist in the fields of stem cell biology, biochemistry, and neuroscience. As a Senior Study Director within our Discovery and Translational Science team, Andrew specializes in planning, coordinating, and interpreting metabolomic studies for academic and pharmaceutical clients across a wide range of disease and therapeutic areas. Prior to Metabolon, Andrew worked at the U.S. Environmental Protection Agency where he focused on developing novel in vitro model systems to study chemical effects on blood-brain barrier and neural development. Andrew loves to use his positive attitude and tireless work ethic to encourage the adoption of metabolomics across various research areas and markets.

Live Webinar: Untargeted Metabolomics: Parsing large amounts of data to make the most of your metabolomics study.

Schedule a Meeting

Latest Resources

Access a wealth of valuable resources to deepen your understanding about metabolomics and the scientific advancements it has empowered.

P7 Homepage Resource Categories
  • All
  • Case Studies (92)
  • Videos (90)
  • eBooks (47)
  • Posters (20)
  • Product Literature (13)
✕

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.